Beyond Air (XAIR) to Release Quarterly Earnings on Monday

Beyond Air (NASDAQ:XAIR) is projected to release its Q2 2026 results after the market closes on Monday, November 10th. Analysts expect the company to announce earnings of ($1.10) per share and revenue of $2.5360 million for the quarter. Beyond Air has set its FY 2026 guidance at EPS.Interested persons may visit the the company’s upcoming Q2 2026 earningresults page for the latest details on the call scheduled for Monday, November 10, 2025 at 4:30 PM ET.

Beyond Air (NASDAQ:XAIR) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($1.53) EPS for the quarter, missing analysts’ consensus estimates of ($1.50) by ($0.03). Beyond Air had a negative return on equity of 232.61% and a negative net margin of 880.72%.The company had revenue of $1.76 million during the quarter, compared to the consensus estimate of $1.75 million. On average, analysts expect Beyond Air to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Beyond Air Stock Performance

NASDAQ:XAIR opened at $2.06 on Monday. The business’s fifty day moving average is $2.36 and its 200 day moving average is $3.14. The firm has a market cap of $16.34 million, a price-to-earnings ratio of -0.17 and a beta of 0.30. The company has a debt-to-equity ratio of 0.92, a quick ratio of 2.71 and a current ratio of 3.24. Beyond Air has a 52-week low of $1.81 and a 52-week high of $13.52.

Analyst Ratings Changes

XAIR has been the topic of several research analyst reports. Weiss Ratings restated a “sell (e)” rating on shares of Beyond Air in a research report on Tuesday, October 14th. D Boral Capital raised shares of Beyond Air to a “strong-buy” rating in a research note on Thursday, July 17th. Wall Street Zen cut shares of Beyond Air from a “hold” rating to a “sell” rating in a research report on Saturday, August 16th. Finally, D. Boral Capital reaffirmed a “buy” rating and set a $11.00 price objective on shares of Beyond Air in a report on Thursday, August 21st. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $11.00.

Hedge Funds Weigh In On Beyond Air

An institutional investor recently raised its position in Beyond Air stock. Osaic Holdings Inc. grew its position in shares of Beyond Air, Inc. (NASDAQ:XAIR) by 26.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 162,560 shares of the company’s stock after acquiring an additional 34,000 shares during the period. Osaic Holdings Inc. owned about 3.11% of Beyond Air worth $29,000 as of its most recent SEC filing. 31.50% of the stock is currently owned by hedge funds and other institutional investors.

About Beyond Air

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.